Literature DB >> 1777504

Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes.

R Ebner1, R Derynck.   

Abstract

Two structurally related but different polypeptide growth factors, epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha), exert their activities after interaction with a common cell-surface EGF/TGF-alpha-receptor. Comparative studies of the effects of both ligands have established that TGF-alpha is more potent than EGF in a variety of biological systems. This observation is not explained by differences in affinities of the ligands for the receptor, because the affinity-constants of both factors are very similar. We have compared the intracellular processing of ligand-receptor complexes using either EGF or TGF-alpha in two different cell systems. We found that TGF-alpha dissociates from the EGF/TGF-alpha-receptor at much higher pH than EGF, which may reflect the substantial difference in the calculated isoelectric points. After internalization, the intracellular TGF-alpha is more rapidly cleared than EGF, and a substantial portion of the released TGF-alpha represents undegraded TGF-alpha in contrast to the mostly degraded EGF. In addition, TGF-alpha did not induce a complete down-regulation of cell surface receptors, as observed with EGF, which is at least in part responsible for a much sooner recovery of the ligand-binding ability after down-regulation, in the case of TGF-alpha. These differences in processing of the ligand-receptor complexes may explain why TGF-alpha exerts quantitatively higher activities than EGF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1777504      PMCID: PMC361851          DOI: 10.1091/mbc.2.8.599

Source DB:  PubMed          Journal:  Cell Regul        ISSN: 1044-2030


  63 in total

1.  Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies.

Authors:  J R Glenney; W S Chen; C S Lazar; G M Walton; L M Zokas; M G Rosenfeld; G N Gill
Journal:  Cell       Date:  1988-03-11       Impact factor: 41.582

2.  Transforming growth factor alpha production and epidermal growth factor receptor expression in normal and oncogene transformed human mammary epithelial cells.

Authors:  E M Valverius; S E Bates; M R Stampfer; R Clark; F McCormick; D S Salomon; M E Lippman; R B Dickson
Journal:  Mol Endocrinol       Date:  1989-01

3.  Structure and function of human amphiregulin: a member of the epidermal growth factor family.

Authors:  M Shoyab; G D Plowman; V L McDonald; J G Bradley; G J Todaro
Journal:  Science       Date:  1989-02-24       Impact factor: 47.728

4.  Induction of transforming growth factor-alpha in activated human alveolar macrophages.

Authors:  D K Madtes; E W Raines; K S Sakariassen; R K Assoian; M B Sporn; G I Bell; R Ross
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Detection of human lung epithelial cell growth factors produced by a lung carcinoma cell line: use in culture of primary solid lung tumors.

Authors:  J M Siegfried
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

7.  Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors.

Authors:  R Derynck; D V Goeddel; A Ullrich; J U Gutterman; R D Williams; T S Bringman; W H Berger
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

8.  Cell migration is essential for sustained growth of keratinocyte colonies: the roles of transforming growth factor-alpha and epidermal growth factor.

Authors:  Y Barrandon; H Green
Journal:  Cell       Date:  1987-09-25       Impact factor: 41.582

9.  Distinct vascular actions of epidermal growth factor-urogastrone and transforming growth factor-alpha.

Authors:  B S Gan; M D Hollenberg; K L MacCannell; K Lederis; M E Winkler; R Derynck
Journal:  J Pharmacol Exp Ther       Date:  1987-07       Impact factor: 4.030

Review 10.  Allosteric regulation of the epidermal growth factor receptor kinase.

Authors:  J Schlessinger
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  71 in total

1.  The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing.

Authors:  H Waterman; I Alroy; S Strano; R Seger; Y Yarden
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Expression of epidermal growth factor and transforming growth factor alpha in interfacial membranes retrieved at revision total hip arthroplasty.

Authors:  J W Xu; J Ma; T F Li; E Waris; A Alberty; S Santavirta; Y T Konttinen
Journal:  Ann Rheum Dis       Date:  2000-10       Impact factor: 19.103

3.  Bipartite tetracysteine display reveals allosteric control of ligand-specific EGFR activation.

Authors:  Rebecca A Scheck; Melissa A Lowder; Jacob S Appelbaum; Alanna Schepartz
Journal:  ACS Chem Biol       Date:  2012-06-05       Impact factor: 5.100

4.  Prepubertal ethanol exposure alters hypothalamic transforming growth factor-α and erbB1 receptor signaling in the female rat.

Authors:  Vinod K Srivastava; Jill K Hiney; W Les Dees
Journal:  Alcohol       Date:  2010-10-06       Impact factor: 2.405

5.  Mechanism of Allosteric Coupling into and through the Plasma Membrane by EGFR.

Authors:  Julie K L Sinclair; Allison S Walker; Amy E Doerner; Alanna Schepartz
Journal:  Cell Chem Biol       Date:  2018-05-03       Impact factor: 8.116

6.  Endosomal receptor kinetics determine the stability of intracellular growth factor signalling complexes.

Authors:  A Rami Tzafriri; Elazer R Edelman
Journal:  Biochem J       Date:  2007-03-15       Impact factor: 3.857

7.  Essential role of c-Cbl in amphiregulin-induced recycling and signaling of the endogenous epidermal growth factor receptor.

Authors:  Aleksander Baldys; Monika Göoz; Thomas A Morinelli; Mi-Hye Lee; John R Raymond; Louis M Luttrell; John R Raymond
Journal:  Biochemistry       Date:  2009-02-24       Impact factor: 3.162

8.  An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors.

Authors:  S Carvalho; M Lindzen; M Lauriola; N Shirazi; S Sinha; A Abdul-Hai; K Levanon; J Korach; I Barshack; Y Cohen; A Onn; G Mills; Y Yarden
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

9.  Met receptor tyrosine kinase degradation is altered in response to the leucine-rich repeat of the Listeria invasion protein internalin B.

Authors:  Xiu Gao; Marta Lorinczi; Kristen S Hill; Natasha C Brooks; Hatem Dokainish; Keith Ireton; Lisa A Elferink
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

10.  Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers.

Authors:  A E Lenferink; R Pinkas-Kramarski; M L van de Poll; M J van Vugt; L N Klapper; E Tzahar; H Waterman; M Sela; E J van Zoelen; Y Yarden
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.